- Home
- CTRN vs SIGA Comparison
CTRN vs SIGA Comparison
Compare CTRN & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRN | SIGA |
|---|---|---|
| Founded | 1946 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.6M | 401.0M |
| IPO Year | 2005 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CTRN | SIGA |
|---|---|---|
| Price | $51.10 | $5.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $52.00 | N/A |
| AVG Volume (30 Days) | 59.7K | ★ 492.2K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.99% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | ★ $753,079,000.00 | N/A |
| Revenue This Year | $6.89 | N/A |
| Revenue Next Year | $6.48 | $132.36 |
| P/E Ratio | ★ N/A | $16.08 |
| Revenue Growth | ★ 0.69 | N/A |
| 52 Week Low | $16.82 | $4.95 |
| 52 Week High | $56.78 | $9.62 |
Technical Indicators
Market Signals| Indicator | CTRN | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 60.06 | 27.09 |
| Support Level | $39.15 | N/A |
| Resistance Level | N/A | $6.98 |
| Average True Range (ATR) | 2.76 | 0.28 |
| MACD | -0.06 | -0.11 |
| Stochastic Oscillator | 55.10 | 1.32 |
Price Performance
Historical ComparisonAbout CTRN Citi Trends Inc.
Citi Trends Inc is a retailer of urban fashion apparel and accessories in the United States. The company offers apparel, including fashion sportswear for men and women, as well as children, such as newborns, infants, toddlers, boys, and girls; accessories comprising handbags, jewelry, footwear, belts, intimate apparel, scrubs, and sleepwear; and functional and decorative home products, as well as beauty products, books and toys.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.